Abstract: A voltage converter includes a driving device unit, a current sensing unit and a switching control circuit. The driving device unit charges an input power supply voltage in an inductor, connected between a switching node and an output node, in response to a first driving control signal, and discharges the inductor in response to a second driving control signal. The current sensing unit generates first and second sensing signals based on a first sensed current, a second sensed current, a voltage at the switching node and a ground voltage. The switching control circuit generates the first and second driving control signals by performing a pulse-frequency modulation (PFM) and a pulse-width modulation (PWM) based on a feedback voltage, a reference voltage and the first and second sensing signals. The switching control circuit adaptively adjusts off-time when the switching control circuit performs the PFM.

Abstract: A voltage converter includes a converting circuit and a switching control circuit, where the converting circuit includes an inductor connected to a switching node, a first switching device connected between the switching node and a common voltage and a second switching device connected to the switching node, where the first switching device charges the inductor and discharges the inductor in response to a control signal, and the switching control circuit generates the control signal by performing a PWM and a PFM based on a first sensing signal, a second sensing signal and a feedback signal, and adjusts a charging time of the inductor on a time basis, based on at least the input power supply voltage when the switching control circuit performs the PFM.

Abstract: A voltage converter includes a driving device unit, a current sensing unit and a switching control circuit. The driving device unit charges an input power supply voltage in an inductor, connected between a switching node and an output node, in response to a first driving control signal, and discharges the inductor in response to a second driving control signal. The current sensing unit generates first and second sensing signals based on a first sensed current, a second sensed current, a voltage at the switching node and a ground voltage. The switching control circuit generates the first and second driving control signals by performing a pulse-frequency modulation (PFM) and a pulse-width modulation (PWM) based on a feedback voltage, a reference voltage and the first and second sensing signals. The switching control circuit adaptively adjusts off-time when the switching control circuit performs the PFM.

Abstract: In a clock-based soft-start circuit configured to generate a soft-start reference voltage that restrains an inrush current at an initialization of power supplied to a DC-DC converter, the clock-based soft-start circuit comprises a time setting unit configured to set a soft-start time period in response to a clock signal. A ramp circuit is configured to generate a soft-start reference voltage which is ramped upward or downward between a base level and a reference voltage level during the soft start time period set by the time setting unit. In this manner, the clock-based soft-start circuit is applicable for all DC-DC converters and the soft-start in a linear slope is possible.

Abstract: A hybrid charge pump including a hybrid circuit configured to snub an over shoot or under shoot present in an input pulse in a snubbing operation if a level of the pulse is a first level, store the pulse in a charging operation if the level of the pulse is a second level different from the first level, and generate a negative voltage from the stored pulse in a negative voltage generation operation.

Abstract: A hybrid charge pump including a hybrid circuit configured to snub an over shoot or under shoot present in an input pulse in a snubbing operation if a level of the pulse is a first level, store the pulse in a charging operation if the level of the pulse is a second level different from the first level, and generate a negative voltage from the stored pulse in a negative voltage generation operation.

Abstract: In a clock-based soft-start circuit configured to generate a soft-start reference voltage that restrains an inrush current at an initialization of power supplied to a DC-DC converter, the clock-based soft-start circuit comprises a time setting unit configured to set a soft-start time period in response to a clock signal. A ramp circuit is configured to generate a soft-start reference voltage which is ramped upward or downward between a base level and a reference voltage level during the soft start time period set by the time setting unit. In this manner, the clock-based soft-start circuit is applicable for all DC-DC converters and the soft-start in a linear slope is possible.

Abstract: The present invention relates to a polypeptide derived from a highly conserved region (HCR) I-III of an extracellular region of a CD99 and CD99 family such as CD99L2 and PBDX(or XG), which are a kind of transmembrane protein, or a fused protein thereof. The polypeptide or the fused protein thereof has an activating function of inhibiting the extravasation of white blood cells, or inhibiting the growth and/or metastasis of cancer cells. The present invention also provides a polynucleotide coding the polypeptide, a vector including same, and a transformant transformed by the vector. In addition, the present invention provides a pharmaceutical composition including the polypeptide or the fused protein thereof for preventing or treating inflammatory diseases. Further, the present invention provides a is pharmaceutical composition including the polypeptide or the fused protein thereof inhibiting the growth and/or metastasis of cancer cells, i.e., a pharmaceutical composition for preventing or treating cancer.

Abstract: The present invention relates to a polypeptide derived from a highly conserved region (HCR) I-III of an extracellular region of a CD99 and CD99 family such as CD99L2 and PBDX (or XG), which are a kind of transmembrane protein, or a fused protein thereof. The polypeptide or the fused protein thereof has an activating function of inhibiting the extravasation of white blood cells, or inhibiting the growth and/or metastasis of cancer cells. The present invention also provides a polynucleotide coding the polypeptide, a vector including same, and a transformant transformed by the vector. In addition, the present invention provides a pharmaceutical composition including the polypeptide or the fused protein thereof for preventing or treating inflammatory diseases. Further, the present invention provides a pharmaceutical composition including the polypeptide or the fused protein thereof inhibiting the growth and/or metastasis of cancer cells, i.e., a pharmaceutical composition for preventing or treating cancer.

Abstract: Described is a polypeptide inhibiting the transmigration of leukocytes or the growth and/or metastasis of cancer cells, a fusion protein thereof, a polynucleotide encoding the polypeptide, a vector including the polynucleotide, and a transformant transformed with the vector. Described is also a pharmaceutical composition for the prevention or treatment of inflammatory diseases, or the inhibition of the growth and/or metastasis of cancer cells including the polypeptide or a fusion protein thereof.

Abstract: A method of fabricating an extended drain MOS transistor which reduces a design rule and prevents the generation of leakage current. The method includes sequentially forming a diffusion film, a first conductive epitaxial layer, a gate oxide layer and a hard mask layer over a semiconductor substrate, forming a first hard mask pattern having a first thickness by performing a first etching process on the hard mask layer, forming a second hard mask pattern having a second thickness by performing a second etching process on the first hard mask layer, and then forming a thin gate oxide layer by performing a third etching process on the gate oxide layer using the second hard mask pattern as a mask.

Abstract: Disclosed are a polarizer, a method for fabricating the same, and a liquid crystal display having the same. The liquid crystal display includes a liquid crystal panel and a polarizer attached to the liquid crystal panel. The polarizer includes a polarizing film, a first support film, and a second support film. The first support film has optical anisotropy and is attached to the polarizing film. The first support film has a first thickness. The second support film is attached to the polarizing film while facing the first support film and has a second thickness, which is greater than the first thickness. The polarizer is fabricated by evaporating a solvent from a solution including polymer resin to form an optical film and then elongating the optical film.

Abstract: Disclosed are a polarizer, a method for fabricating the same, and a liquid crystal display having the same. The liquid crystal display includes a liquid crystal panel and a polarizer attached to the liquid crystal panel. The polarizer includes a polarizing film, a first support film, and a second support film. The first support film has optical anisotropy and is attached to the polarizing film. The first support film has a first thickness. The second support film is attached to the polarizing film while facing the first support film and has a second thickness, which is greater than the first thickness. The polarizer is fabricated by evaporating a solvent from a solution including polymer resin to form an optical film and then elongating the optical film.

Abstract: The present invention provides a polypeptide inhibiting the transmigration of leukocytes or the growth and/or metastasis of cancer cells, or a fusion protein thereof. The present invention also provides a polynucleotide encoding the polypeptide, a vector including the polynucleotide, and a transformant transformed with the vector. The present invention also provides a pharmaceutical composition for the prevention or treatment of inflammatory diseases including the polypeptide or a fusion protein thereof. The present invention also provides a pharmaceutical composition for inhibiting the growth and/or metastasis of cancer cells including the polypeptide or a fusion protein thereof.

Abstract: Disclosed are a polarizer, a method for fabricating the same, and a liquid crystal display having the same. The liquid crystal display includes a liquid crystal panel and a polarizer attached to the liquid crystal panel. The polarizer includes a polarizing film, a first support film, and a second support film. The first support film has optical anisotropy and is attached to the polarizing film. The first support film has a first thickness. The second support film is attached to the polarizing film while facing the first support film and has a second thickness, which is greater than the first thickness. The polarizer is fabricated by evaporating a solvent from a solution including polymer resin to form an optical film and then elongating the optical film.

Abstract: Disclosed is a liquid crystal display panel having an ion trap structure and a liquid crystal display including the same. The liquid crystal display panel has an opening area and a non-opening area and includes a first substrate, a second substrate that faces the first substrate, and a liquid crystal layer interposed between the first and the second substrates. The first substrate includes a plurality of unit pixels and a first alignment film having a first area and a second area. The first area of the first alignment film is disposed on the opening area, the second area is disposed on the non-opening area, and the second area is thinner than the first area.

Abstract: A method of fabricating an extended drain MOS transistor which reduces a design rule and prevents the generation of leakage current. The method includes sequentially forming a diffusion film, a first conductive epitaxial layer, a gate oxide layer and a hard mask layer over a semiconductor substrate, forming a first hard mask pattern having a first thickness by performing a first etching process on the hard mask layer, forming a second hard mask pattern having a second thickness by performing a second etching process on the first hard mask layer, and then forming a thin gate oxide layer by performing a third etching process on the gate oxide layer using the second hard mask pattern as a mask.

Abstract: A liquid crystal display device includes an LCD panel, a polarizer assembly having a polarizer and a compensation film, and an adhesive layer. The adhesive layer adheres the polarizer assembly to the LCD panel and has an exfoliation force of 16 N/25 mm to 28 N/25 mm. The adhesive layer is formed of acryl polymer and a crosslinking agent with a respective weight ratio of 75:25 to 90:10, or about 85:15.

Abstract: Disclosed are a polarizer, a method for fabricating the same, and a liquid crystal display having the same. The liquid crystal display includes a liquid crystal panel and a polarizer attached to the liquid crystal panel. The polarizer includes a polarizing film, a first support film, and a second support film. The first support film has optical anisotropy and is attached to the polarizing film. The first support film has a first thickness. The second support film is attached to the polarizing film while facing the first support film and has a second thickness, which is greater than the first thickness. The polarizer is fabricated by evaporating a solvent from a solution including polymer resin to form an optical film and then elongating the optical film.

Abstract: In a liquid crystal display having a polarizing plate, the polarizing plate includes a polarizing film to polarize a light, a supporting film, and a surface film. The supporting film is arranged on the polarizing film and includes a scattering material to scatter the polarized light. The surface film is arranged on the supporting film. Thus, the liquid crystal display uses the light having uniform intensity to display the image.